Why the study?
Does antihypertensive treatment reduce electronmicroscopic pathologic changes in vital organs in calves with a total artificial heart?
Does antihypertensive treatment reduce electronmicroscopic pathologic changes in vital organs in calves with a total artificial heart?
Antihypertensive treatment in calves with a total artificial heart prolonged survival but did not significantly alter electronmicroscopic ischemic changes in the kidneys and lungs compared to untreated animals.
Antihypertensive treatment extends survival in artificial heart calves without reducing most organ EM changes; leaves open mechanisms and human relevance.
Electronmicroscopic (EM) evaluation of selected vital organs (liver, kidney, lung) informs us about otherwise hardly detectable changes during total artificial heart (TAH) pumping. In our experiments, we compared 2 groups of long-surviving animals in which the TAH TNS-BRNO pneumatic device was implanted (TNS-BRNO-II and VII in 45 experiments, TNS-BRNO-III in 1 experiment, and TNS-BRNO-VIII in 1 experiment). In 4 experiments, the Rostock TAH (NABEL, TAH Research Center, Rostock, Germany) was implanted. One group of 22 animals with an average survival of 162 days (the longest, 293 days) was submitted to an antihypertensive treatment; another 1 of 29 calves with an average survival of 98 days (the longest, 173 days) was untreated. The evaluation was performed using a scale (0 to 3) based on very precisely fixed criteria. EM pathologic changes documented various stages of ischemic damage. Except for the liver, no significant difference was found between both groups, despite the substantially prolonged survival in the treated group. Very important was the general state of mitochondria, endoplasmic reticulum, and nucleus. Further, the state of glomerular podocytes in the kidney and the state of interalveolar septa and of pneumocytes constituting the air-blood barrier for gas exchange in the lungs are especially important. In some animals of both groups, the EM findings were completely normal, especially in the lung.
No takes yet. Share an insight, caveat, or question.
Vašků et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: